University of Groningen
Non-cardiac comorbidities in heart failure with preserved ejection fraction
Streng, Koen Wouter
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Streng, K. W. (2019). Non-cardiac comorbidities in heart failure with preserved ejection fraction: Focussing
on obesity and renal dysfunction. University of Groningen.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.
Stellingen
Non-cardiac Comorbidities in Heart Failure
with Preserved Ejection Fraction
Focussing on obesity and renal dysfunction
Koen W. Streng
1. Obesity influences biomarker levels in heart failure patients, but does not influence their prognostic value - this thesis 2. Abdominal fat is associated with worse outcome, especially in women with heart failure - this thesis 3. The usage of RAAS inhibitors in patients with HFpEF should be reconsidered when renal function decreases - this thesis 4. Increasing protein intake in heart failure patients might be a promising non-pharmacological intervention 5. Renal damage markers are elevated in HFpEF patients with preserved renal function, suggesting a common denominator in HFpEF and renal failure 6. The management of HFpEF should include treating comorbidities, instead of solely focussing on HFpEF 7. Quality of life is often undervalued in heart failure studies8. Association is not equal to causation - Michael Floyd’s cat in the Times 9. Massa is kassa - Anonymous
